1. Anthracycline versus no anthracycline neoadjuvant therapy for HER2 breast cancer: real world evidence. (November 2022) Authors: Soares De Pinho, I.; Simão, D.; Roldán Galanares, M.; Lopes-Brás, R.; Patel, V.; Esperança-Martins, M.; Gonçalves, L.; Alves, L.; Fernandes, I.; Gamez Casado, S.; Artacho Criado, S.; Baena Cañada, J.; Costa, J.; Fernandes, A.S.; Teixeira de Sousa, R.; Costa, L.; Luz, P. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fear of death among young breast cancer patients during adjuvant endocrine therapy. (October 2020) Authors: Luz, P.; Carvalho, A.Nobre; Oliveira, A.; Menezes, M.; Dinis, R.; Gosalbez, B. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P159 Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio are not predictive of Pathologic Complete Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer. (April 2023) Authors: de Pinho, I. Soares; Barroso, T.; Trabulo, C.; Campoa, E.; Patel, V.; Gonçalves, L.; Araújo, J.; Monteiro, C.; Ferreira, A.; Machado, B.; Dâmaso, S.; Luz, P.; de Sousa, R. Teixeira; Costa, L. Journal: Breast Issue: Volume 68(2023) Page Start: S77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Post neoadjuvant HER2 treatment: real world data from a multicentric cohort. (April 2021) Authors: Luz, P.; Fernandes, I.; Diaz Acedo, R.; Gamez Casado, S.; Campoa, E.; Alves, L.; Arede, A.J.; Lomares, I.; Baena Cañada, J.; Magalhães, J.; Fernandes, A.; Costa, J.G.; Gosalbez, B. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The evaluation of tumor-infiltrating lymphocytes (TILs) in early breast cancer: differences between histologic subtypes in a Portuguese cohort. (April 2021) Authors: Luz, P.; Fernandes, I.; Arede, A.J.; Campoa, E.; Alves, L.; Enrique Morera, J.L.; Gosalbez, B.; Costa, J.G.; Fernandes, A. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗